Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Sernova Corp T.SVA

Alternate Symbol(s):  SEOVF

Sernova Corp. is a Canada-based clinical-stage biotechnology company, which is developing therapeutic cell technologies for chronic diseases, including insulin-dependent diabetes, thyroid disease, and blood disorders that include hemophilia A. The Company is focused on developing a functional cure for insulin-dependent diabetes with its therapeutic cell technology, the Cell Pouch System, a novel implantable and scalable medical device with immune protected therapeutic cells. The Cell Pouch is a scalable, implantable medical device. The Cell Pouch is designed to create a vascularized organ-like environment for the transplantation and engraftment of therapeutic cells. Its regenerative medicine therapeutic approach is to provide cell therapies where the cells, transplanted within an organ-like vascularized implantable device, the Cell Pouch, generates proteins, hormones or factors released into the bloodstream for treatment of diseases requiring replacement of these molecules in the body.


TSX:SVA - Post by User

Comment by BioTeckon Feb 03, 2021 11:56pm
211 Views
Post# 32467416

RE:RE:RE:RE:RE:RE:RE:J$ summary

RE:RE:RE:RE:RE:RE:RE:J$ summary I agree with clutchbuyer. The money involved here is chump change. I nearly have the amount of commons involved in this deal. There is more than meets the eye here, not just a quick cash grab. Insiders have not sold anything yet, if they knew a PP was coming and were as shady as people here are making them sound they would have sold some into the rally and topped up with a warrant to boot. You can't have a year and a bit of runway left at this juncture. Pharma needs to take you seriously and see you're equipped to go the whole way without their help. Could they have done the PP at 2 bucks, probably not or else they would have. I wouldn't have paid 2 bucks after a meteoric rise like that, not a chance. The stock has barely been trading over a dollar for a month. I never liked management because I think they are inexperienced and get bullied around by everyone. But they are progressing well with the science. Much better than I expected. I got burnt with buying at 1.65 and all the way down to 1.20 but it was worth it then and nothing has changed except for a few million shares. I'm not selling any shares. I'll let you know when I do.
could it dip down, sure there will likely be some shareholders holding from 30 cents and below who have had enough and sell their positions and move on but I would like to think Canaccord and leede will be there to soak it up. You don't put out a price target of 2.50 for your firms clients and then screw them.
<< Previous
Bullboard Posts
Next >>